High expression of ANXA3, ARG1 and HP was strongly associated with lower survival in late-stage LC cases (hazard ratios (HRs) = 2.81, 2.16 and 2.54, respectively). This evidence concerns the gene ARG1 and laryngotracheoesophageal cleft.